Pharmapedia Pro
Medicines/Generics/Ranibizumab

Ranibizumab

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Ranibizumab ophthalmic (for the eyes) is used in adults to treat the "wet form" of age-related macular degeneration . Ranibizumab is also used in adults to treat swelling in the retina caused by diabetes , or a blockage in blood vessels. Ranibizumab can also be used in adults to treat diabetic retinopathy , and myopia caused by abnormal growth of new blood vessels in the retina. Ranibizumab may also be used for purposes not listed in this medication guide.
Indications
Ranibizumab ophthalmic (for the eyes) is used in adults to treat the "wet form" of age-related macular degeneration . Ranibizumab is also used in adults to treat swelling in the retina caused by diabetes , or a blockage in blood vessels. Ranibizumab can also be used in adults to treat diabetic retinopathy , and myopia caused by abnormal growth of new blood vessels in the retina. Ranibizumab may also be used for purposes not listed in this medication guide.
Contraindications
You should not receive ranibizumab if you are allergic to it, or if you have: swelling, redness, pain inside or around your eyes; or any type of infection in or around your eyes. Tell your doctor if you have or have ever had: an eye infection; retinal detachment; a heart attack , or stroke ; glaucoma or other condition that increases pressure inside your eyes; or taken certain other medicines that can increase bleeding risk such as warfarin , aspirin , or nonsteroidal anti-inflammatory drugs (NSAID). It is not known if ranibizumab will harm an unborn baby. Use effective birth control while using ranibizumab and for at least 12 months after your last dose. Tell your doctor if you are pregnant or plan to become pregnant. Ask a doctor if it is safe to breastfeed while using ranibizumab.
Side Effects
Get emergency medical help if you have signs of an allergic reaction : hives, difficult breathing, swelling of your face, lips, tongue, or throat. Ranibizumab may cause serious side effects. Call your doctor at once if you have: increased eye pain, swelling, or redness in your eye; vision loss, sensitivity to light; blurred vision, seeing halos around lights; feeling like something is in your eye; discharge or watery eyes; sudden changes in your vision, seeing flashes of light; or a "spider webs" appearance in your vision. Common side effects of ranibizumab may include: eye pain; sensitivity to light; "floaters" in your vision; increased pressure inside the eye; or eye redness or a blood spot on the white of your eye. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
You should not receive ranibizumab if you have swelling, redness, pain inside your eyes, or any type of infection in or around your eyes. Call your doctor at once if you have sudden vision problems, eye pain, redness, discharge, or watering in your eye, or if your eyes are more sensitive to light.
High Risk Groups
You should not receive ranibizumab if you have swelling, redness, pain inside your eyes, or any type of infection in or around your eyes. Call your doctor at once if you have sudden vision problems, eye pain, redness, discharge, or watering in your eye, or if your eyes are more sensitive to light.
Adult Dosage
0.5 mg (0.5 (0.5)) As recommended. intravitreal — once a month (approximately 28 days). Although less effective, treatment may be reduced to one injection every three months after the first four injections if monthly injections are not feasible. Compared to continued monthly dosing, dosing every 3 months will lead to an approximate 5-letter (1-line) loss of visual acuity benefit, on average, over the following 9 months. Patients should be evaluated regularly. Adequate anesthesia and a broad-spectrum microbicide should be given prior to the intravitreal injection.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
Medicine used in the eyes is not likely to be affected by other drugs you use. But many drugs can interact. Tell your doctor about all your current medicines, including prescription and over-the-counter medicines, vitamins , and herbal products .
Storage
Inj Do not Freeze. Protect from Sunlight. Use within mentioned date, if refrigerated.

Available Brands in Pakistan

No active brands are currently recorded for this generic.

1 record is present but flagged "Unverified / Legacy" and excluded.